Cite
HARVARD Citation
Van de Vondel, S. et al. (2018). Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis. Inflammatory bowel diseases. 24 (5), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Van de Vondel, S. et al. (2018). Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis. Inflammatory bowel diseases. 24 (5), p. . [Online].